NCT05586867View on ClinicalTrials.gov

Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2031

Conditions
Iron Metabolism DisordersCalcium Phosphate MetabolismHepatic Metabolic DisordersHemodialysis Complication
Interventions
PROCEDURE

Blood test

15 mL of blood to follow the evolution of hepcidin and erythroferrone levels

Trial Locations (1)

91480

RECRUITING

Hôpital Privé Claude Galien, Quincy-sous-Sénart

Sponsors
All Listed Sponsors
collaborator

European Clinical Trial Experts Network

OTHER

lead

Ramsay Générale de Santé

OTHER

NCT05586867 - Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients | Biotech Hunter | Biotech Hunter